INmune Bio Inc. (INMB) Stock Total Returns
Growth of $10,000 chart
2021-04-21 to 2026-04-21 to
$
%
%
Loading chart…
Investment Performance
Final Value
$1,051
Total Return
-89.49%
CAGR
-36.27%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -0.85% |
| Median | -3.96% |
| Best | +118.49% |
| Worst | -73.86% |
| % of Windows Positive | 41.1% |
1-Year (252 Trading Days)
| Average | -24.53% |
| Median | -27.11% |
| Best | +87.77% |
| Worst | -86.46% |
| % of Windows Positive | 23.1% |
3-Year (756 Trading Days)
| Average | -51.13% |
| Median | -66.44% |
| Best | +34.67% |
| Worst | -87.06% |
| % of Windows Positive | 11.8% |
Risk Metrics
| Maximum Drawdown | -95.98% |
| Average Drawdown | -68.38% |
| Drawdown Duration | 1159 Trading Days (Unrecovered) |
| Sortino Ratio | -0.10 |
| Calmar Ratio | -0.38 |
| CVaR (5%) | -11.30% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -12.18% (-34.78% ann.) | $1217.96 | $0.00 | $0.00 | $0.00 |
| 2025 | -66.60% | $6659.53 | $0.00 | $0.00 | $0.00 |
| 2024 | -58.53% | $5852.57 | $0.00 | $0.00 | $0.00 |
| 2023 | +77.60% | +$7760.25 | $0.00 | $0.00 | $0.00 |
| 2022 | -37.84% | $3784.31 | $0.00 | $0.00 | $0.00 |
| 2021 | -40.77% | $4076.65 | $0.00 | $0.00 | $0.00 |
| 2020 | +196.90% | +$19689.67 | $0.00 | $0.00 | $0.00 |
| 2019 partial | -27.41% (-29.85% ann.) | $2740.93 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | February 4, 2019 – February 19, 2020 | -36.46% | -35.33% | $3645.81 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -54.44% | -99.99% | $5444.24 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +205.16% | +502.03% | +$20515.89 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +62.02% | +58.05% | +$6201.55 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -43.58% | -45.54% | $4357.98 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -22.27% | -12.71% | $2226.89 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 21, 2026 | -73.60% | -56.78% | $7360.31 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.